This report covers the findings of the 7-year assessment of EIT Health Knowledge and Innovation Community conducted by White Research and Deloitte. EIT Health is a vibrant community including some of the world’s leading health innovators. EIT Health has a pan-EU presence with its seven Regional Innovation Hubs and InnoStars, which is a unique cluster focused on regions with innovation capacity. Launched in January 2022, EIT Health Austria is the newest of the EIT Health Regional Innovation Hubs besides EIT Health Belgium-Netherlands, EIT Health France, EIT Health Germany, EIT Health Scandinavia, EIT Health Spain, EIT Health Ireland-UK. EIT Health has expanded its presence through an EIT Health Regional Innovation Scheme in 12 countries across Central, Eastern and Southern Europe and new Hubs are being established. EIT Health also leads the development of the EIT Hub in Israel, which connects innovators across Europe to other key thriving ecosystems beyond the EU. During the period from 2016 to 2021 the KIC had more than 200 core and associate partners and more than 200 project partners involved across different healthcare sectors. EIT Health has identified six healthcare challenges that shall be tackled to strengthen healthcare systems, promote better health of citizens, and contribute to a sustainable health economy in Europe.
Furthermore, EIT Health was established to promote and manage activities designed to address the changes in Europe related to health and well-being. The KIC’s mission is to promote entrepreneurship and develop innovations in the areas of healthy living and active ageing across Europe and thus enable citizens to lead healthier lives, as well as contribute to the sustainability of healthcare in Europe. EIT Health activities exploit the benefits of connecting innovation, education and entrepreneurship and in this way, implement multidisciplinary projects. EIT Health partners aim to proactively apply their strength and resources towards achieving the goals of the KIC. Together, the partnerships can identify and close competency gaps, connect innovation hubs together and scale up innovations. The COVID-19 crisis highlighted the need for such healthcare collaborations and underlined the value of EIT Health in identifying needs and gaps created by the crisis and implementing appropriate measures in response.
As the first seven-year Framework Partnership Agreements (hereinafter “FPAs”) of EIT Health and EIT RawMaterials draw to a close, a mid-term review is necessary to assess the KICs’ achievements compared with what was promised in their proposals, Strategic Agendas, Business Plans and grant reports. More specifically, the assessment shall review all areas of activities relevant for a KIC. In accordance with requirements in the EIT Strategic Innovation Agenda, Article 12 of the Partnership Agreement and Articles 10 and 11 of the EIT Regulation, a comprehensive assessment was conducted in line with the standards put forth by the Better Regulation Guidelines and the criteria for European Partnerships set out in the Horizon Europe Regulation.
Share this page
